Inventor · disambiguated record
Deog Joong Kim
Also filed as: KIM DEOG J · KIM DEOG JOONG
15 granted patents·5 pending applications·22 citations·filing 2007–2020
88Inventor score
Top patents by PatentIndex Score
20 records- 0189US9150520B2Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-oneREXAHN PHARMACEUTICALS INC·Filed 2014·Granted Oct 6, 2015·8 cites·29 claims
- 0289US8846110B2Polymeric systems for the delivery of anticancer drugsLEE YOUNG B·Filed 2010·Granted Sep 30, 2014·10 cites·20 claims
- 0379US10307490B2Lipid nanoparticle compositions for antisense oligonucleotides deliveryUNIV OHIO STATE·Filed 2013·Granted Jun 4, 2019·1 cites·32 claims
- 0479US9533958B2Process or the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-Enyl)-1H-pyrimidin-2-oneREXAHN PHARMACEUTICALS INC·Filed 2015·Granted Jan 3, 2017·2 cites·20 claims
- 0565US9434610B2HPMA—docetaxel conjugates and uses thereforeLEE YOUNG B·Filed 2009·Granted Sep 6, 2016·0 cites·19 claims
- 0664US8114892B2Methods and compositions for the treatment of Parkinson's DiseaseKIM DEOG JOONG·Filed 2007·Granted Feb 14, 2012·1 cites·1 claims
- 0763US2015071872A1Polymeric systems for the delivery of anticancer drugsREXAHN PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0861US9193707B2Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compoundsLEE YOUNG BOK·Filed 2014·Granted Nov 24, 2015·0 cites·20 claims
- 0959US2020231553A1Quinoxalinyl-piperazinamide methods of useREXAHN PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1059US2009270358A1Pharmaceutical formulation of clavulanic acidREXAHN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1158US9920016B2Process for the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-oneREXAHN PHARMACEUTICALS INC·Filed 2016·Granted Mar 20, 2018·0 cites·16 claims
- 1256US10570101B2Quinoxalinyl-piperazinamide methods of useREXAHN PHARMACEUTICALS INC·Filed 2018·Granted Feb 25, 2020·0 cites·12 claims
- 1356US9744167B2Nanoparticulate compositions and formulations of piperazine compoundsREXAHN PHARMACEUTICALS INC·Filed 2014·Granted Aug 29, 2017·0 cites·19 claims
- 1453US9713615B2Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compoundsREXAHN PHARMACEUTICALS INC·Filed 2015·Granted Jul 25, 2017·0 cites·21 claims
- 1552US10278971B2Fluorocyclopentenylcytosine methods of useREXAHN PHARMACEUTICALS INC·Filed 2017·Granted May 7, 2019·0 cites·17 claims
- 1652US10052321B2Nanoparticulate compositions and formulations of piperazine compoundsREXAHN PHARMACEUTICALS INC·Filed 2017·Granted Aug 21, 2018·0 cites·23 claims
- 1751US9969698B2Quinoxalinyl-piperazinamide methods of useREXAHN PHARMACEUTICALS INC·Filed 2016·Granted May 15, 2018·0 cites·13 claims
- 1851US2019275042A1Fluorocyclopentenylcytosine methods of useREXAHN PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1950US9782410B2Fluorocyclopentenylcytosine methods of useREXAHN PHARMACEUTICALS INC·Filed 2016·Granted Oct 10, 2017·0 cites·21 claims
- 2034US2010255099A1Clavulanate formulation for neuroprotection and treatment of neurodegenerative disordersREXAHN PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →